Moderna Reports Positive COVID-19 Vaccine Response in Kids

Vaccine efficacy against infection was less than 45% in children aged 6 months to 6 years, which the company says is consistent with adult efficacy data during the Omicron surge.
Medscape Medical News

source https://www.medscape.com/viewarticle/970779?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost